Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD11a/CD18 Antibody (hu1124 (Efalizumab)) - Azide and BSA Free, Novus Biologicals™
SDP

Human Monoclonal Antibody

Supplier:  Novus Biologicals NBP2759120.2MG

Catalog No. N27591202M


Only null left
Add to Cart

Description

Description

CD11a/CD18 Monoclonal specifically detects CD11a/CD18 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Block/Neutralize.
Specifications

Specifications

CD11a/CD18
Monoclonal
1 mg/mL
Flow Cytometry, Immunohistochemistry, Block/Neutralize
CD11 antigen-like family member A, CD11a antigen, CD11Aantigen CD11A (p180), lymphocyte function-associated antigen 1, alphapolypeptide, integrin alpha-L, integrin gene promoter, integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen1; alpha polypeptide), Leukocyte adhesion glycoprotein LFA-1 alpha chain, Leukocyte function-associated molecule 1 alpha chain, LFA-1, LFA-1 alpha, LFA1A, LFA-1A, lymphocyte function-associated antigen 1
Human
0.2 mg
3683
Human
IgG1 κ
Flow Cytometry, Immunohistochemistry, Blocking Assay, Neutralization
hu1124 (Efalizumab)
Unconjugated
PBS with 0.02% Proclin 300
ITGAL
Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
Primary
Binds to human LFA-1.
Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.